logo
Hamilton Insurance Group, Ltd. (HG): A Bull Case Theory

Hamilton Insurance Group, Ltd. (HG): A Bull Case Theory

Yahoo21-05-2025

We came across a bullish thesis on Hamilton Insurance Group, Ltd. (HG) on Substack by Karst Research. In this article, we will summarize the bulls' thesis on HG. Hamilton Insurance Group, Ltd. (HG)'s share was trading at $21.26 as of May 20th. HG's trailing P/E was 6.95 according to Yahoo Finance.
A financial analyst presenting a chart of insurance solutions to a boardroom.
Hamilton Insurance Group, Ltd., a Bermuda-based specialty insurer, represents a compelling and underappreciated opportunity in global insurance markets. Operating through its International and Bermuda platforms under the Hamilton Global Specialty, Hamilton Select, and Hamilton Re brands, the company underwrites complex risks across casualty, specialty, and property lines. Its U.S.-focused Hamilton Select targets the fast-growing excess and surplus (E&S) market, while Hamilton Re provides global reinsurance solutions. This diversified structure provides both earnings balance and strategic flexibility.
Under the leadership of seasoned executives from Kinsale, Tokio Marine Kiln, and Chubb, Hamilton has executed a disciplined turnaround, emphasizing pricing rigor and portfolio optimization. This has led to a significant swing in profitability—from underwriting losses in 2022 to $149.4 million in underwriting income in 2024, with premiums written rising to $1.92 billion. The company's strengthening fundamentals are further supported by growing Lloyd's syndicate 4000 capacity, set to rise to GBP635 million in 2025, enabling meaningful international scale. Hamilton's capital strength is equally notable, with a $4.9 billion investment portfolio emphasizing liquidity and quality, including nearly $1 billion in cash and a sophisticated $940 million allocation to a custom Two Sigma 'fund-of-one.' With only $150 million in term debt and an opportunistic $137.6 million share buyback reducing the share count below pre-IPO levels, Hamilton is optimizing capital deployment to enhance shareholder value.
The stock is still overlooked, but the convergence of improving underwriting, strong capital allocation, and structural growth sets up a favorable risk/reward profile for investors, with long-term upside potential as the business continues to scale. Also, check out Skyward (SKWD), a quality insurer focused on niche markets.
Hamilton Insurance Group, Ltd. (HG) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 22 hedge fund portfolios held HG at the end of the fourth quarter which was 18 in the previous quarter. While we acknowledge the risk and potential of HG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than HG but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.
Disclosure: None. This article was originally published at Insider Monkey.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

America's $75 Billion Nuclear Bet: Westinghouse vs. the Future of Energy
America's $75 Billion Nuclear Bet: Westinghouse vs. the Future of Energy

Yahoo

time32 minutes ago

  • Yahoo

America's $75 Billion Nuclear Bet: Westinghouse vs. the Future of Energy

Westinghouse is going all-in on America's nuclear revival. Backed by Brookfield and Cameco, the Pennsylvania-based firm is in active talks with US officials, tech firms, and utilities to build 10 large nuclear reactors under President Trump's new energy directive. The order sets a 2030 deadline to begin construction and aims to quadruple US nuclear output by 2050. That kind of ambition could translate into a $75 billion opportunity, based on Department of Energy cost estimates. Interim CEO Dan Sumner says Westinghouse has the edgeits AP1000 design is approved, the supply chain is intact, and it's already delivered units in the US and China. We believe we can do them all, Sumner told the FT, pointing to hyperscaler interest and government loan programs as signs of momentum. Warning! GuruFocus has detected 2 Warning Sign with AMZN. But it's not a done deal yet. Nuclear still faces stiff economic headwinds in the US. While Washington may be on board, local utilities and regulators still have the final sayand memories of the Vogtle project's ballooning costs still linger. Analysts warn that the current US power market structure doesn't guarantee cost recovery for mega-projects, making investor appetite uncertain. Even so, Sumner argues that lessons from past delays have been baked into the new build model: We're the only ones who've done modular nuclear at scale. And now, the learning's embedded. Meanwhile, SMR developers aren't staying quiet. NuScale is pitching a 12-pack of its 77MW modules to rival traditional plants in capacity, while Holtec's 320MW units could be grouped to matchand beatWestinghouse on cost and complexity. We fully intend to compete with the big plants, Holtec's president said. The big question now: Will deep-pocketed buyersthink Amazon (NASDAQ:AMZN), Google (NASDAQ:GOOG), Microsoft (NASDAQ:MSFT)step up to fund these nuclear ambitions, or wait for the small guys to scale first? Either way, the race is on. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Prime Healthcare cutting about 100 jobs across its Illinois facilities, months after acquiring hospitals from Ascension
Prime Healthcare cutting about 100 jobs across its Illinois facilities, months after acquiring hospitals from Ascension

Yahoo

time42 minutes ago

  • Yahoo

Prime Healthcare cutting about 100 jobs across its Illinois facilities, months after acquiring hospitals from Ascension

Prime Healthcare, which bought eight Illinois hospitals earlier this year, is eliminating more than 100 jobs, the hospital system confirmed Monday. Prime made most of the reductions Friday, and will continue cutting other jobs through July. 'As we continue to offer and create opportunities, we are also evaluating alignment with best practices and support from our national and regional teams,' Prime said in a statement. 'Through this process, there is a small number of positions that are duplicated or not aligned with the care model and service line offerings — most of them not directly providing patient care — that will be consolidated.' None of the affected jobs are union positions, according to Prime. Prime hired 13,000 workers from Ascension when it bought the hospitals from that health system, and has created nearly 1,000 new jobs since the acquisition. The job cuts represent less than 1% of the combined 14,000 employees, according to the statement. 'Importantly, these efforts will not affect the quality of care we deliver to the communities we serve and in fact will help expand best practices from across the nation,' Prime said in the statement. 'All decisions made at our Illinois facilities are guided by our mission to improve quality, strengthen care delivery, preserve access in underserved areas and ensure long-term sustainability.' The California-based Prime bought the Illinois hospitals for more than $370 million in March. Six of the hospitals sold to Prime changed from being nonprofit hospitals to for-profit hospitals as part of the sale. Hospitals that were sold include St. Mary's Hospital in Kankakee, Holy Family Medical Center in Des Plaines, Resurrection Medical Center in Chicago, St. Francis Hospital in Evanston, St. Joseph Medical Center in Joliet, St. Joseph Hospital in Elgin, Mercy Medical Center in Aurora and St. Mary of Nazareth Hospital in Chicago. The job cuts are the latest in a string of changes Prime has made since closing the deal, drawing criticism from elected officials and a nurses union. Prime announced in April that it planned to suspend inpatient pediatric care at St. Joseph Medical Center in Joliet, saying at the time that the unit had been averaging less than one patient a day, while the need for other services such as advanced surgical, neurosurgical and spinal care had grown. The Illinois Nurses Association condemned the move, arguing it would hurt the community, which only has one hospital. Also, Mercy Medical Center in Aurora lost its designation in April as a Level II trauma center. Prime also suspended obstetrical services at St. Mary's in Kankakee after the hospital's 'nearly sole obstetrics physician' retired, and because of low demand, Prime has said. Sens. Dick Durbin and Tammy Duckworth sent a letter to Prime's chairman, founder and CEO Dr. Prem Reddy in May expressing concern about those changes and asking Prime to elaborate on the reasons behind them and its future plans for the hospitals. Prime responded to that letter last week, emphasizing its mission of turning around struggling community hospitals across the country. Prime said that before it bought the hospitals in Illinois they were losing about $200 million a year. Prime said maintaining services with low patient demand is not sustainable, nor good for the quality of care. Prime also told the senators it plans to expand behavioral health care services for seniors at its Illinois facilities. In its statement Monday, Prime said it has started fulfilling a previously stated commitment to invest $250 million across the Illinois hospitals. Prime said those affected by the job cuts are invited to apply for any of the more than 900 open positions across its Illinois facilities. The job cuts were first reported by the Herald News.

US exaggerating Huawei's AI chip achievements, China state media quotes CEO as saying
US exaggerating Huawei's AI chip achievements, China state media quotes CEO as saying

Yahoo

time42 minutes ago

  • Yahoo

US exaggerating Huawei's AI chip achievements, China state media quotes CEO as saying

BEIJING (Reuters) -The United States is exaggerating Huawei's achievements when it comes to the Ascend AI chip, the chief executive of China's Huawei Technologies said, according to Chinese state media. Huawei's founder Ren Zhengfei said the company uses group computing to supplement single chips, according to an article by the People's Daily on Tuesday. The U.S. Commerce Department last month published guidance warning that companies risked violating U.S. export controls by using Huawei's Ascend AI chips, the Shenzhen-based tech company's most advanced semiconductor series.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store